Status:

COMPLETED

Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression

Lead Sponsor:

University of California, San Diego

Conditions:

Stress

Anxiety

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The purpose of this study is to determine how effective Kelee meditation is in improving stress, anxiety, and depression.

Detailed Description

The Kelee and Kelee meditation (KM) were developed and founded by Ron W. Rathbun. KM is a unique and distinctive form of meditation that is easy to learn and requires only about 10 minutes twice a day...

Eligibility Criteria

Inclusion

  • Documented HIV-1 infection
  • Ages 18 to 65
  • Experiencing some level of stress, anxiety, or depression
  • No current use of other meditation practices or holistic modalities

Exclusion

  • Non-English readers or speakers
  • Hearing-impaired
  • Low literacy below 5th grade reading and comprehension level

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT01527955

Start Date

September 1 2008

End Date

June 1 2011

Last Update

February 7 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Being Alive San Diego

San Diego, California, United States, 92103

2

University of California, San Diego Medical Center

San Diego, California, United States, 92103